Skip to main content

Table 1 Summary of the treatment planning objectives and the radiobiological parameters used in the evaluation

From: Dose mapping sensitivity to deformable registration uncertainties in fractionated radiotherapy – applied to prostate proton treatments

ROI

 

α/β

CTV

N/A

1.5

PTV

Minimise V(D<33.0 Gy)

N/A

 

Minimise V(D>34.7 Gy)

 

Rectum

Minimise V(D>29.6 Gy)

3.0

Bladder

Minimise V(D>29.6 Gy)

3.0